Trifecta Capital Advisors, LLC 10x Genomics, Inc. Transaction History
Trifecta Capital Advisors, LLC
- $601 Billion
- Q2 2025
A detailed history of Trifecta Capital Advisors, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 29,200 shares of TXG stock, worth $378,432. This represents 0.06% of its overall portfolio holdings.
Number of Shares
29,200Holding current value
$378,432% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding TXG
# of Institutions
321Shares Held
121MCall Options Held
330KPut Options Held
156K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13.9MShares$180 Million1.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$161 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL7.1MShares$92.1 Million0.02% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$82.8 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.02MShares$78 Million0.04% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.23B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...